Shanghai, China

Yuelin Wu



 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 93(Granted Patents)


Location History:

  • Pudong New District, CN (2013)
  • Shanghai, CN (2010 - 2014)
  • Pudong District, CN (2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Yuelin Wu: Innovator in SGLT2 Inhibitor Development

Introduction

Yuelin Wu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceutical sciences. He holds a total of seven patents, showcasing his innovative approach to developing compounds that target sodium-dependent glucose cotransporters (SGLT).

Latest Patents

Among his latest patents, Wu has developed processes for the preparation of SGLT2 inhibitors. These processes are designed to create complexes that aid in purifying compounds with an inhibitory effect on SGLT. Notably, these methods can reduce the number of steps required to obtain the target compounds, and the resulting complexes are typically provided in a crystalline form. Another significant patent involves benzylbenzene derivatives and their methods of use. This invention includes compounds that inhibit SGLT, along with pharmaceutical compositions, methods for preparing these compounds, synthetic intermediates, and applications for treating diseases influenced by SGLT inhibition.

Career Highlights

Yuelin Wu has worked with notable companies such as Theracos, Inc. and Theracos Sub, LLC. His work in these organizations has contributed to advancements in the pharmaceutical industry, particularly in the development of innovative treatments for various health conditions.

Collaborations

Wu has collaborated with esteemed colleagues, including Shengbin Li and Yuanwei Chen, further enhancing the impact of his research and inventions.

Conclusion

Yuelin Wu's innovative work in the development of SGLT2 inhibitors and related compounds has made a significant impact in the pharmaceutical field. His contributions continue to pave the way for new therapeutic options in treating diseases associated with glucose transport.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…